Pharma Focus Europe-Newsletter
Pharma Focus Europe
Pharma Focus Europe is a Bi-Annual publication from Ochre Media Pvt. Ltd.
Trending Topics
As a novel healing technique, gene therapy targets core issues in hereditary diseases. This is another approach where damaged genes are altered or removed; this has a ray of hope in diseases like SCID, SMA, hemophilia, and LCA. Despite challenges such as delivery methods and ethics, the potential of gene therapy continue to revolutionize medicine. Read further
The age of generative AI is a major shift in drug discovery, speeding up development and improving efficiency. This article is going to provide us with a critical analysis of how generative AI is changing the biotech industry, discussing technologies, applications, challenges, and the new options developed, that were never seen in the past. It even feels like faster and more effective therapeutic advancements are on the horizon, where new diseases are planned for and cures for old ones are rapid. Learn more
Telemedicine and telecare, m-health, wearable devices, electronic health records, and big data analytics are the digital health technologies that are becoming the agents of change in the health care systems by enhancing access, self-management by patients, early disease diagnosis, fine-tuning of individual care, and reduced costs. These enhancements provide positive changes in patients’ health, safety, and chronic diseases and facilitate preventive care, besides enhancing cohesiveness among caregivers, thus changing the healthcare system. Explore further
Drug patents are central in the pharmaceutical field because they offer marketing privileges over drugs, foster technological advancement, and control the market. They drive the research expenditure, make research financially rewarding for firms, and determine the costs and availability of drugs. However, controversies still surround them concerning their pace and the effects on equity in international health. Learn more
Professional Insights
Dear Readers, Welcome to our panel discussion on Biopharmaceuticals and Biosimilars: Market Trends and Future Prospects. Our esteemed panelists, Barbara Hendrickson , Gillian Woollett and Christopher Conway , will share their expertise on regulatory strategies, market dynamics, and innovative trends shaping the biopharmaceutical landscape. Join us as we delve into the evolving world of biopharmaceuticals and biosimilars, exploring insights that promise to shape the future of the pharmaceutical industry. Discover more
Author: Kishore Hotha, PhD, MBA , Veranova
One of the fastest-growing modalities in the pharmaceutical industry, antibody-drug conjugates (ADCs), combines a targeted antibody with a cytotoxic payload to offer numerous therapeutic benefits. Veranova’s experts have a deep understanding of the challenges involved in ADC development and have explored how advanced techniques such as preparative chromatography can help streamline the process.
Authors: Marty Boom , Navitas Life Sciences
Our proposed content will explore targeted applications of Gen AI within pharmacovigilance and regulatory affairs, highlighting its potential to streamline processes, improve decision-making, and ultimately, drive better outcomes for all stakeholders.
Industrial Projects
Thermo Fisher Scientific to Expand Kentucky Clinical Research Facility with $47.8 Million Investment
Thermo Fisher Scientific Inc.'s PPD clinical research business is embarking on a significant expansion of its central laboratory operations in Kentucky. Learn more
Novo Nordisk has announced a $4.1 billion USD (approximately 27 billion Danish kroner) investment to build a new fill and finishing manufacturing facility in Clayton, North Carolina. Explore more
The leading CDMO is currently installing key equipment for its latest sterile fill-finish facility, including twin lyophilizers and a state-of-the-art large-scale isolator filling line. Read more
Merck is investing over €300 million in a new research center at its global headquarters in Darmstadt, Germany. Discover more
Recent Technological Innovations
The Elecsys pTau217 assay, developed by Roche in collaboration with Eli Lilly and Company, is a blood test designed to detect amyloid pathology. Learn more
领英推荐
Dizal's recent announcement regarding the FDA's grant of breakthrough therapy. The approval stems from compelling data from the global phase I/II study, WU-KONG1, showcasing sunvozertinib's efficacy as a first-line treatment. Read more
Researchers at the University of Pennsylvania devised a breakthrough technique for creating HACs from designer DNA, sidestepping issues with DNA constructs. Learn more
White Papers
Authors: Richard Johnson , Upperton Pharma Solutions
Drug products containing active biological ingredients form one of the most important and fastest-growing sectors of the pharmaceutical industry. These biologics include a wide range of large, complex molecules, including protein and peptide products (such as monoclonal antibodies), through to more complex moieties, including vaccines and oligonucleotides incorporated into lipid-based delivery vehicles. Read more
Authors: Sammy Sambu, DPhil (Oxon), IOD (KE) , Kate Coleman , Steve Gens MSOD - Gens and Associates Inc. , Klaus Menges , Scott Cleve , Timm Pauli , Jürgen H?nig - PharmaLex ,
When COVID-19 disrupted life sciences, solutions were needed in real-time. As the pandemic grew, so did the need to innovate. Workers met the challenges. They completed tasks, fulfilled inspections, and remained vigilant in fulfilling regulatory requirements. This paper presents findings from a roundtable hosted by PharmaLex. It examines how life science professionals leveraged disruptive technologies during the pandemic. In the talks, industry leaders focused on what worked well, what needs to be improved, and what comes next. The program included six topics, Learn more
After more than three decades of fast economic growth, China has entered the “new normal” stage, marked by a moderate and stable domestic GDP growth rate. Healthcare has been elevated to a national-level agenda by the current leadership with the release of “China Health 2030. Diecover more
Insightful Articles
Authors: Mena Abdelsayed, Ph.D. , Claude Capdepon
Artificial intelligence (AI) has revolutionized the field of scientific applications, particularly in biotechnology and medicine. By leveraging AI, medical devices and drugs are now designed and optimized more efficiently, accelerating the drug discovery process and competitive analysis. My expertise in biotechnology underscores AI's transformative role in advancing medical technology, from streamlining market research with large language models to enhancing drug and device design. AI not only saves time and costs by predicting efficacy and toxicity but also aids in structuring clinical trials and patient recruitment, making it an indispensable tool in modern medical innovation. Read more
Authors: Oliver Cram, Catherine K. Markopoulou, Dr.Jnanadeva Bhat and Manali Dalvi
In the race to meet the increasing demand for new pharmaceutical products, capsules, as a preferred choice for many drug developments, offer a transformative solution to the challenges associated with the process. Delve into the myriad ways capsules streamline the process, alleviating time constraints and resource burdens while meeting the demands of a rapidly evolving industry. This article explores the efficiency and cost-effectiveness of capsules in accelerating the journey of new drug entities from research to market.
Author: Arun Om Lal
Delving into the realm of nutraceuticals, this article illuminates the fusion of nutrition and pharmaceuticals as a cornerstone of modern health consciousness. From its inception by Stephen De Felice to its transformative impact amidst COVID-19, the piece navigates through regulatory complexities, market dynamics, and emerging innovations. Embracing overall wellness, it advocates for informed consumer choices and proactive healthcare paradigms. Read more
Author: Deepak Khurana CPSCM?
Lean supply chain management in the pharmaceutical industry is of great concern as it involves patients’ lives. Drug shortages occur very often & cause severe supply chain disruptions. Lean supply chain management starts before a drug is manufactured. The article will cover different aspects of the lean supply chain, challenges in implementing LSC, and the implementation of the lean supply chain in the industry. Learn more
Latest Press Releases